Target | cis/trans | Study | SNP | SNP location | Maj/min allele | MAF | N | βinv | seinv | Pinv | fclog | Plog | Praw |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
sLeptin R | cis | Discovery | rs4655537 | 1:66,058,801 | G/A | 0.35 | 994 | 0.350 | 0.044 | 7.4×10-15 | 1.240 | 5.8×10-16 | 6.4×10-16 |
sLeptin R | cis | Replication | rs4655537 | 1:66,058,801 | G/A | 0.37 | 337 | 0.389 | 0.066 | 1×10-8 | 1.250 | 2.1×10-10 | 1.6×10-8 |
Target (abbrv.) | sLeptin R |
Target (full name) | Leptin receptor |
Somalogic ID (Sequence ID) | SL003184 (5400-52_3) |
Entrez Gene Symbol | LEPR |
UniProt ID | P48357 |
UniProt Comment |
|
Targeted by drugs (based on IPA annotation) |
|
Biomarker applications (based on IPA annotation) |
|
Wiki Pathways |
|
Pathway Interaction Database |
|
Reactome |
|
All locus annotations are based on the sentinel SNP (rs4655537) and 1 proxy variant(s) that is/are in linkage disequilibrium r2 ≥ 0.8. Linkage disequilibrium is based on data from the 1000 Genomes Project, phase 3 version 5, European population and was retrieved using SNiPA's Block Annotation feature.
Download the detailed results of SNiPA's block annotation (PDF)
Genes hit or close-by |
|
Trait | P | Study | Source |
---|---|---|---|
Plasma soluble leptin receptor (sOB-R) levels | 2.8×10-12 | 20167575 (PMID) | GRASP2 nonQTL |
C-reactive protein (CRP) | 6.6×10-10 | 23505291 (PMID) | GRASP2 nonQTL |
Plasma C-reactive protein (female) | 3.3×10-9 | 18439548 (PMID) | GRASP2 nonQTL |
Baseline acute-phase serum amyloid concentrations | 1.6×10-8 | 21124955 (PMID) | GRASP2 nonQTL |
cg00046625 (chr1:66258784) | 1.1×10-6 | 10.1101/033084 (DOI) | BIOS QTL cis-meQTLs |